Yuelu Yin

Title: Yuelu Yin: Innovator in T Cell Receptor Technology

Introduction

Yuelu Yin is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of immunology through his innovative work on T cell receptors. His research focuses on enhancing the recognition of specific epitopes, which is crucial for effective drug development.

Latest Patents

Yuelu Yin holds a patent for the MART-1 (27-35) epitope-specific T cell receptor. This invention comprises an α chain and a β chain, with the α chain containing three complementary determining regions. The specific sequences of these regions are located at positions 61-66, 84-89, and 124-136 of SEQ ID No. 3. The β chain also includes three complementary determining regions, with amino acid sequences at positions 46-50, 68-73, and 112-125 of SEQ ID No. 4. A T cell expressing this TCR can effectively recognize a MART-1 (27-35) epitope polypeptide supported on a T2 cell and secrete IFN-γ, demonstrating the receptor's functionality. This TCR can be utilized with relevant drug targets, facilitating effective drug development.

Career Highlights

Yuelu Yin is currently employed at BGI Shenzhen, where he continues to advance his research in T cell receptor technology. His work has positioned him as a key figure in the field, contributing to the understanding and application of T cell receptors in therapeutic contexts.

Collaborations

Yuelu collaborates with notable colleagues, including Fei Wang and Chengchi Chao. Their combined expertise enhances the research environment and fosters innovation in their projects.

Conclusion

Yuelu Yin's contributions to T cell receptor technology exemplify the impact of innovative research in immunology. His patent for the MART-1 (27-35) epitope-specific T cell receptor represents a significant advancement in the field, paving the way for future developments in drug therapy.